Price Movement and Market Context
On 5 Oct 2026, Strides Pharma’s stock closed at ₹1,082.95, down 3.12% from the previous close of ₹1,117.85. The intraday range was between ₹1,076.25 and ₹1,117.60, indicating some volatility within the session. Despite this recent dip, the stock remains well above its 52-week low of ₹769.60, though still below the 52-week high of ₹1,260.10.
Comparatively, Strides Pharma has outperformed the Sensex significantly over multiple time horizons. Year-to-date, the stock has gained 20.01%, while the Sensex has declined 15.62%. Over one year, Strides Pharma’s return stands at 32.20% against the Sensex’s negative 11.20%. Even over a longer term of five years, the stock has delivered a remarkable 305.95% return, dwarfing the Sensex’s 22.37% gain.
Technical Trend Shift: From Bullish to Mildly Bullish
The overall technical trend for Strides Pharma has shifted from bullish to mildly bullish, reflecting a more cautious outlook among traders and analysts. This subtle change is evident in the mixed signals from key technical indicators.
The Moving Averages on the daily chart remain bullish, suggesting that the short-term momentum is still positive. However, weekly and monthly indicators present a more complex picture. The weekly MACD remains bullish, but the monthly MACD has turned mildly bearish, indicating a potential weakening in longer-term momentum.
Similarly, the Bollinger Bands show a mildly bullish stance on both weekly and monthly timeframes, implying moderate upward price pressure but with limited volatility expansion. The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, suggesting the stock is neither overbought nor oversold at these intervals.
Patience pays off here! This Micro Cap from Fertilizers sector has delivered steady gains quarter after quarter. Now proudly part of our Reliable Performers list.
- - New Reliable Performer
- - Steady quarterly gains
- - Fertilizers consistency
Additional Technical Indicators: KST, Dow Theory, and OBV
The Know Sure Thing (KST) indicator, which helps identify momentum shifts, is mildly bearish on both weekly and monthly charts. This suggests that while short-term momentum remains positive, there is some underlying weakness in the broader trend.
Dow Theory analysis shows a bullish trend on the weekly timeframe but no clear trend on the monthly scale. This divergence highlights the uncertainty in the stock’s longer-term direction.
On-Balance Volume (OBV) is bullish on the weekly chart, indicating that volume supports recent price gains. However, the monthly OBV shows no discernible trend, reinforcing the mixed signals from other monthly indicators.
Mojo Score and Grade Adjustment
Reflecting these technical nuances, MarketsMOJO has adjusted Strides Pharma’s Mojo Grade from Buy to Hold as of 1 Oct 2026. The current Mojo Score stands at 67.0, placing the stock in the Hold category. This downgrade signals a more cautious stance, advising investors to monitor developments closely before committing fresh capital.
Strides Pharma remains classified as a small-cap stock within the Pharmaceuticals & Biotechnology sector, which is known for its volatility and sensitivity to regulatory and innovation-driven news.
Considering Strides Pharma Science Ltd? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this small-cap with top-rated alternatives now!
- - Better options discovered
- - Pharmaceuticals & Biotechnology + beyond scope
- - Top-rated alternatives ready
Investor Implications and Outlook
Investors should note that the recent price momentum shift and mixed technical signals suggest a period of consolidation or moderate correction may be underway. The daily moving averages’ bullish stance offers some support, but the mildly bearish monthly MACD and KST indicators warrant caution.
Given the stock’s strong historical outperformance relative to the Sensex—delivering over 365% returns in three years and 305% in five years—Strides Pharma remains an attractive long-term holding. However, the current technical environment advises a more measured approach, especially for short-term traders.
Market participants should watch for confirmation of trend direction from upcoming weekly and monthly technical readings. A sustained break below key moving averages or a deterioration in volume patterns could signal a deeper correction. Conversely, renewed bullish momentum in MACD and KST indicators would support a resumption of the uptrend.
Summary of Key Technical Metrics
- Current Price: ₹1,082.95 (down 3.12% on 5 Oct 2026)
- 52-Week Range: ₹769.60 – ₹1,260.10
- Mojo Score: 67.0 (Hold), downgraded from Buy on 1 Oct 2026
- Moving Averages (Daily): Bullish
- MACD: Weekly Bullish, Monthly Mildly Bearish
- RSI: No clear signal on weekly and monthly charts
- Bollinger Bands: Mildly Bullish on weekly and monthly
- KST: Mildly Bearish on weekly and monthly
- Dow Theory: Weekly Bullish, Monthly No Trend
- OBV: Weekly Bullish, Monthly No Trend
In conclusion, Strides Pharma Science Ltd’s technical landscape is currently characterised by a cautious optimism. While short-term indicators maintain a bullish bias, longer-term signals suggest the need for vigilance. Investors should balance the stock’s impressive historical returns with the present mixed technical outlook when making portfolio decisions.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
